Drug intelligence / Profile preview

Cicatridina

Development stage
Unknown
Lead developer
FARMA-DERMA
Administration
Intranasal, Rectal, Topical, Vaginal
01

Overview

Cicatridina is a brand of tissue-repair and wound-healing products developed by Farma-Derma and distributed in various markets, including Switzerland by Hygis. The primary active ingredient is hyaluronic acid (as sodium hyaluronate), a mucopolysaccharide that serves as a structural component of the extracellular matrix. Hyaluronic acid facilitates tissue repair by providing hydration and creating a scaffold for cell migration and proliferation. Cicatridina is most commonly marketed as vaginal ovules for the treatment of atrophic vaginitis and vaginal dryness, but it is also available in spray and ointment forms for topical wound healing, surgical scars, and proctological conditions. The formulation often includes botanical extracts such as *Aloe vera*, *Calendula officinalis*, and *Centella asiatica* to provide additional soothing and anti-inflammatory effects.

Brand names
Cicatridina
Other names
Cicatridina ovulesCicatridina sprayCicatridina ointment
02

Targets

CD44 (CD44 antigen)HMMR

Beyond the preview

Go deeper on Cicatridina.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cicatridina.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call